Arkolith/Insider Trading/BVS/Form 4

Claypoole Robert E

President and CEO, DirectorBioventus Inc. (BVS) · full profile →Form 4 · filed Mar 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
2 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Option exercise(M)34K—$0150K
Mar 13, 2026Tax withholding(F)15K$8.62$125K136K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 13, 2026Grant(A)309K—$0309K
Mar 13, 2026Option exercise(M)34K—$0101K
Mar 13, 2026Grant(A)278K—$0278K
Mar 14, 2025Grant(A)153K—$0153K
Mar 14, 2025Grant(A)134K—$0134K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002005474-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML